On Feb 14th, the Government issued a notification reducing the prices of coronary stents by up to 400 per cent, capping them at Rs 7,260 for bare metal ones and Rs 29,600 for the drug eluting variety. Currently, the maximum retail cost of a stent currently ranges from Rs 25,000 to Rs 1.98 lakh.
As per some, this move will bring a major relief to lakhs of cardiac patients by capping stent prices. India has one of the lowest earning capacities in the world and the high cost of catastrophic illnesses make it beyond the reach of vast majority of Indians. On the other hand, others are questioning whether the profit-driven medical institutions will actually pass on the benefit to patients, or find ways to recover the considerable cost difference from them.
Do you think this benefit will reach the common man or will the institutes find a way around it by relocating the charges?
Share your views...
Source:The Indian Express